New York, NY
- February 9, 2004 - Manhattan Scientifics, Inc. (MHTX) announced
today that it has delivered a 700-watt NovArs prototype fuel cell
system to the U.S. Army under a contract received in the third quarter
of last year. The contract was awarded as part of the Army's Communications-Electronics
Command's (CECOM) competitive Foreign Technology Evaluation Program.
Manhattan Scientifics'
management said the unit is being evaluated by CECOM with other
units as a possible battery charger for tactical units.
A prototype
NovArs fuel cell unit of the type being evaluated by the Department
of Defense Fuel Cell Test and Evaluation Center (FCTec) was featured
in several fuel cell publications and showcased at a recent fuel
cell conference in Florida. A copy of the article can be accessed
by visiting the MHTX website at http://www.mhtx.com/.
Manhattan Scientifics'
COO Jack Harrod said, "We are pleased that the Department of
Defense is testing our NovArs fuel cell technology. It is too early
to speculate on the long term implications of this activity."
About Manhattan
Scientifics
Manhattan Scientifics, Inc. (www.mhtx.com)
is a technology development company working in the fields of alternative
energy, and computer touch technology. The company's development
laboratories are located in Los Alamos and Albuquerque, New Mexico.
Its executive facility is located in New York City. Copies of Manhattan
Scientifics' press releases, current quotes, stock charts and other
information for investors may be found on the website
www.hawkassociates.com
www.hawkmicrcocaps.com
The foregoing
press release contains forward-looking statements (including expectation
of future events), which are subject to risks, and uncertainty,
which may be beyond the company's control. Actual results could
differ materially for many reasons including but not limited to
completion of R&D and successful commercialization of products/services,
patent completion, prosecution and defense against well-capitalized
competitors. These are serious risks and there is no assurance that
our forward-looking statements will occur or prove to be accurate.
Executive Contacts:
Marvin Maslow, CEO, Manhattan
Scientifics (917) 923-3300.
Email:maslow@ix.netcom.com
Jack Harrod
Chief Operating Officer
Manhattan Scientifics, Inc.
214.675.8033
Email:harrod@airmail.net
Media Contact: Richard
Rubenstein, Rubenstein PR (212) 843-9222
Email: rruben@rpr1.com
Investor Relations Contact:
Frank Hawkins, (Hawk Associates) (305) 852-2383
Email: Info@hawkassociates.com